Table 3.
Completion rates and incidence of TEAEs leading to discontinuation by actual (last) daily perampanel dose in the presence and absence of EIAEDs (safety set of studies 304, 305, and 306)
Completion rates and incidence of TEAEs leading to discontinuation by actual (last) daily perampanel dose in the presence and absence of EIAEDs (safety set of studies 304, 305, and 306)